Thermo Fisher Scientific Inc. (TMO) to Distribute Quarterly Dividend of $0.22 on October 15th

Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Thursday, July 9th, RTT News reports. Shareholders of record on Tuesday, September 15th will be paid a dividend of 0.22 per share by the medical research company on Thursday, October 15th. This represents a $0.88 dividend on an annualized basis and a yield of 0.23%.

Thermo Fisher Scientific has a payout ratio of 7.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Thermo Fisher Scientific to earn $14.26 per share next year, which means the company should continue to be able to cover its $0.88 annual dividend with an expected future payout ratio of 6.2%.

Shares of NYSE:TMO opened at $382.57 on Friday. The company has a current ratio of 2.32, a quick ratio of 1.69 and a debt-to-equity ratio of 0.67. Thermo Fisher Scientific has a 12-month low of $250.21 and a 12-month high of $395.00. The company has a market cap of $153.11 billion, a PE ratio of 31.09, a price-to-earnings-growth ratio of 2.49 and a beta of 1.04. The stock has a 50 day moving average of $351.88 and a 200 day moving average of $327.77.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, April 22nd. The medical research company reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.15. The company had revenue of $6.23 billion during the quarter, compared to the consensus estimate of $6.18 billion. Thermo Fisher Scientific had a net margin of 14.31% and a return on equity of 17.25%. Thermo Fisher Scientific’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.81 EPS. Equities research analysts predict that Thermo Fisher Scientific will post 12.48 earnings per share for the current fiscal year.

Several analysts recently issued reports on TMO shares. SVB Leerink increased their target price on Thermo Fisher Scientific from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, April 23rd. Needham & Company LLC lifted their price objective on shares of Thermo Fisher Scientific from $383.00 to $415.00 and gave the company a “buy” rating in a research report on Tuesday. Stifel Nicolaus lowered their target price on shares of Thermo Fisher Scientific from $345.00 to $315.00 and set a “buy” rating on the stock in a report on Thursday, April 2nd. Citigroup raised their target price on shares of Thermo Fisher Scientific from $365.00 to $390.00 and gave the company a “buy” rating in a research note on Thursday, April 23rd. Finally, Cowen reissued a “buy” rating and set a $380.00 price objective on shares of Thermo Fisher Scientific in a report on Monday, July 6th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $357.42.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction on Monday, June 1st. The shares were sold at an average price of $348.00, for a total transaction of $870,000.00. Following the completion of the transaction, the chief financial officer now directly owns 37,989 shares of the company’s stock, valued at $13,220,172. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 20,000 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $349.89, for a total transaction of $6,997,800.00. Following the completion of the sale, the chief executive officer now directly owns 294,946 shares in the company, valued at approximately $103,198,655.94. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 97,500 shares of company stock worth $33,044,350. Company insiders own 0.44% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Treasury Bonds

Dividend History for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.